167 related articles for article (PubMed ID: 19430512)
1. [Idiotype vaccines in the treatment of follicular lymphoma: current status and future perspectives].
Zabalegui N; López Díaz de Cerio A; Inogés S; Soria E; Villanueva H; Rivero P
An Sist Sanit Navar; 2009; 32(1):61-73. PubMed ID: 19430512
[TBL] [Abstract][Full Text] [Related]
2. Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma.
Inogès S; Rodrìguez-Calvillo M; Zabalegui N; Lòpez-Dìaz de Cerio A; Villanueva H; Soria E; Suárez L; Rodríguez-Caballero A; Pastor F; García-Muñóz R; Panizo C; Pèrez-Calvo J; Melero I; Rocha E; Orfao A; Bendandi M; ;
J Natl Cancer Inst; 2006 Sep; 98(18):1292-301. PubMed ID: 16985248
[TBL] [Abstract][Full Text] [Related]
3. Idiotype vaccination in follicular lymphoma: knocking on the doorway to cure.
Longo DL
J Natl Cancer Inst; 2006 Sep; 98(18):1263-5. PubMed ID: 16985240
[No Abstract] [Full Text] [Related]
4. Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
[TBL] [Abstract][Full Text] [Related]
5. Translational development of vaccination strategies in follicular NHL.
Sakamaki I; Qin H; Kwak LW
Best Pract Res Clin Haematol; 2011 Jun; 24(2):295-304. PubMed ID: 21658625
[TBL] [Abstract][Full Text] [Related]
6. Idiotype vaccine strategies for treatment of follicular lymphoma.
Mahaseth H; Brody JD; Sinha R; Shenoy PJ; Flowers CR
Future Oncol; 2011 Jan; 7(1):111-22. PubMed ID: 21174542
[TBL] [Abstract][Full Text] [Related]
7. BiovaxID idiotype vaccination: active immunotherapy for follicular lymphoma.
Flowers CR
Expert Rev Vaccines; 2007 Jun; 6(3):307-17. PubMed ID: 17542746
[TBL] [Abstract][Full Text] [Related]
8. Phase III randomized study of autologous lymphoma-derived idiotype specific vaccination plus GM-CSF in patients with follicular lymphoma in first complete remission.
Clin Adv Hematol Oncol; 2003 Jan; 1(1):67. PubMed ID: 16227966
[No Abstract] [Full Text] [Related]
9. Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study.
Yáñez R; Barrios Y; Ruiz E; Cabrera R; Díaz-Espada F
J Immunother; 2008 Apr; 31(3):310-2. PubMed ID: 18317357
[TBL] [Abstract][Full Text] [Related]
10. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.
Bertinetti C; Simon F; Zirlik K; Heining-Mikesch K; Pfeifer D; Osterroth F; Rosenthal FM; Veelken H
Eur J Haematol; 2006 Nov; 77(5):395-402. PubMed ID: 16879605
[TBL] [Abstract][Full Text] [Related]
11. Active immunotherapy in follicular lymphoma.
Veelken H
Semin Cancer Biol; 2003 Jun; 13(3):241-7. PubMed ID: 12959355
[TBL] [Abstract][Full Text] [Related]
12. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
13. Intraclonal variability of VH genes in follicular lymphoma patients who have received anti-idiotypic immunotherapy.
Yáñez R; Barrios Y; Cabrera R; Díaz-Espada F
J Immunother; 2006; 29(1):61-6. PubMed ID: 16365601
[TBL] [Abstract][Full Text] [Related]
14. Identifying patients with follicular lymphoma who are likely to benefit from an idiotype vaccine.
Ansell SM; Suman VJ
J Clin Oncol; 2011 Jul; 29(20):2748-9. PubMed ID: 21632499
[No Abstract] [Full Text] [Related]
15. Vaccination strategies in follicular lymphoma.
Kannan S; Neelapu SS
Curr Hematol Malig Rep; 2009 Oct; 4(4):189-95. PubMed ID: 20425407
[TBL] [Abstract][Full Text] [Related]
16. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study.
McCormick AA; Reddy S; Reinl SJ; Cameron TI; Czerwinkski DK; Vojdani F; Hanley KM; Garger SJ; White EL; Novak J; Barrett J; Holtz RB; Tusé D; Levy R
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10131-6. PubMed ID: 18645180
[TBL] [Abstract][Full Text] [Related]
17. Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
Hurvitz SA; Timmerman JM
Curr Opin Oncol; 2005 Sep; 17(5):432-40. PubMed ID: 16093791
[TBL] [Abstract][Full Text] [Related]
18. Current advances, problems and prospects for vaccine-based immunotherapy in follicular non-Hodgkin's lymphoma.
Dermime S; Aljurf MD
Leuk Lymphoma; 2005 Apr; 46(4):497-507. PubMed ID: 16019477
[TBL] [Abstract][Full Text] [Related]
19. Vaccination strategies in the treatment of lymphomas.
Veelken H; Osterroth F
Oncology; 2002; 62(3):187-200. PubMed ID: 12065865
[TBL] [Abstract][Full Text] [Related]
20. Idiotype vaccination as consolidation therapy: time for integration into standard of care for follicular lymphoma?
Schuster SJ; Neelapu SS; Santos CF; Popa-McKiver MA; McCord AM; Kwak LW
J Clin Oncol; 2011 Dec; 29(36):4845-6. PubMed ID: 22042953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
